Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
European Myeloma Network Consensus on next-gen sequencing for prognostic stratification of NDMM suggests broader list of events be incorporated, test should be offered at least to fit patients, and should be repeated at relapse.”
Title: European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
Authors: Niccolò Bolli, Mattia D’Agostino, Tina Bagratuni, Mario Boccadoro, Michele Cavo, Christoph Driessen, Hermann Einsele, Monika Engelhardt, Francesca Gay, Norma C. Gutiérrez, Roman Hájek, Toril Holien, Cristina João, Martin Kaiser, K. Martin Kortüm, Lisa Leypoldt, Philippe Moreau, Pellegrino Musto, Enrique M. Ocio, Marc S. Raab, Leo Rasche, Fredrik Schjesvold, Tereza Sevcikova, Evangelos Terpos, Cyrille Touzeau, Niels W. C. J. Van de Donk, Mark van Duin, Katja Weisel, Elena Zamagni, Tom Cupedo, Pieter Sonneveld, Carolina Terragna
You can read the Full Article in Hemasphere.
You can find more posts featuring Robert Orlowski on OncoDaily.
